Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Gray Matter Hypertrophy and Thickening with Obstructive Sleep Apnea in Middle-aged and Older Adults.

Baril AA, Gagnon K, Brayet P, Montplaisir J, De Beaumont L, Carrier J, Lafond C, L'Heureux F, Gagnon JF, Gosselin N.

Am J Respir Crit Care Med. 2017 Jan 6. doi: 10.1164/rccm.201606-1271OC. [Epub ahead of print]

PMID:
28060546
2.

Is rigorous retrospective harmonization possible? Application of the DataSHaPER approach across 53 large studies.

Fortier I, Doiron D, Little J, Ferretti V, L'Heureux F, Stolk RP, Knoppers BM, Hudson TJ, Burton PR; International Harmonization Initiative..

Int J Epidemiol. 2011 Oct;40(5):1314-28. doi: 10.1093/ije/dyr106.

3.

Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies.

Fortier I, Burton PR, Robson PJ, Ferretti V, Little J, L'Heureux F, Deschênes M, Knoppers BM, Doiron D, Keers JC, Linksted P, Harris JR, Lachance G, Boileau C, Pedersen NL, Hamilton CM, Hveem K, Borugian MJ, Gallagher RP, McLaughlin J, Parker L, Potter JD, Gallacher J, Kaaks R, Liu B, Sprosen T, Vilain A, Atkinson SA, Rengifo A, Morton R, Metspalu A, Wichmann HE, Tremblay M, Chisholm RL, Garcia-Montero A, Hillege H, Litton JE, Palmer LJ, Perola M, Wolffenbuttel BH, Peltonen L, Hudson TJ.

Int J Epidemiol. 2010 Oct;39(5):1383-93. doi: 10.1093/ije/dyq139.

4.

Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study.

Bélanger SA, Vanasse M, Spahis S, Sylvestre MP, Lippé S, L'heureux F, Ghadirian P, Vanasse CM, Levy E.

Paediatr Child Health. 2009 Feb;14(2):89-98.

5.

Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results.

Broocks A, Pigott TA, Hill JL, Canter S, Grady TA, L'Heureux F, Murphy DL.

Psychiatry Res. 1998 Jun 2;79(1):11-20.

PMID:
9676822
6.

Reversal of P-glycoprotein-associated multidrug resistance by ivermectin.

Pouliot JF, L'Heureux F, Liu Z, Prichard RK, Georges E.

Biochem Pharmacol. 1997 Jan 10;53(1):17-25.

PMID:
8960059
7.

Obsessive compulsive disorder: comorbid conditions.

Pigott TA, L'Heureux F, Dubbert B, Bernstein S, Murphy DL.

J Clin Psychiatry. 1994 Oct;55 Suppl:15-27; discussion 28-32. Review.

PMID:
7961529
8.

Fluorimetric evaluation of the affinities of isoprenylated peptides for lipid bilayers.

Silvius JR, l'Heureux F.

Biochemistry. 1994 Mar 15;33(10):3014-22.

PMID:
8130214
9.

Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.

Grady TA, Pigott TA, L'Heureux F, Hill JL, Bernstein SE, Murphy DL.

Am J Psychiatry. 1993 May;150(5):819-21.

PMID:
8480832
10.

CSF somatostatin in obsessive-compulsive disorder.

Altemus M, Pigott T, L'Heureux F, Davis CL, Rubinow DR, Murphy DL, Gold PW.

Am J Psychiatry. 1993 Mar;150(3):460-4.

PMID:
8094599
11.

A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.

Pigott TA, Hill JL, Grady TA, L'Heureux F, Bernstein S, Rubenstein CS, Murphy DL.

Biol Psychiatry. 1993 Jan 1;33(1):3-14.

PMID:
8420593
12.

A preliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive compulsive disorder.

Rubenstein CS, Pigott TA, L'Heureux F, Hill JL, Murphy DL.

J Clin Psychiatry. 1992 Sep;53(9):309-14.

PMID:
1517192
13.

A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder.

Pigott TA, L'Heureux F, Rubenstein CS, Bernstein SE, Hill JL, Murphy DL.

J Clin Psychopharmacol. 1992 Jun;12(3):156-62.

PMID:
1629380
14.

Seizure associated with fluoxetine and adjuvant buspirone therapy.

Grady TA, Pigott TA, L'Heureux F, Murphy DL.

J Clin Psychopharmacol. 1992 Feb;12(1):70-1. No abstract available.

PMID:
1552045
15.

A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.

Pigott TA, L'Heureux F, Hill JL, Bihari K, Bernstein SE, Murphy DL.

J Clin Psychopharmacol. 1992 Feb;12(1):11-8.

PMID:
1552034
16.

Seasonal variation in obsessive-compulsive disorder: preliminary experience with light treatment.

Yoney TH, Pigott TA, L'Heureux F, Rosenthal NE.

Am J Psychiatry. 1991 Dec;148(12):1727-9.

PMID:
1957938
17.

Symptoms of eating disorders in patients with obsessive-compulsive disorder.

Pigott TA, Altemus M, Rubenstein CS, Hill JL, Bihari K, L'Heureux F, Bernstein S, Murphy DL.

Am J Psychiatry. 1991 Nov;148(11):1552-7.

PMID:
1928472
18.

A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder.

Pigott TA, Pato MT, L'Heureux F, Hill JL, Grover GN, Bernstein SE, Murphy DL.

J Clin Psychopharmacol. 1991 Aug;11(4):242-8.

PMID:
1918422

Supplemental Content

Loading ...
Support Center